Close

Valeant Pharma (VRX) Subsidiary Bausch and Lomb Granted FDA Approval of LUMIFY

December 22, 2017 3:05 PM EST Send to a Friend
Bausch + Lomb, a leading global eye health company and wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login